 |
|
|
|
|
Utah Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing UtahLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Echelon Biosciences Inc.
| | | | | Phone: | (801) 588-0455 | | Fax: | (801) 588-0497 | | Year Established: | 1997 | | Employees: | 34 | | Main Contact: | Bert Israelsen, COO | | | | Other Contacts: | Colin G. Ferguson, Ph.D., Director of Applied Tech
Paul Neilsen, Ph.D.,, Director, R&D
Charles (Chad) Testa, Ph.D., VP, R&D
W. Tim Miller, MBA, President & CEO
| | | | Company Description | | Echelon Biosciences, a subsidiary of Frontier Scientific Services, is a leader in the rapidly emerging field of transduction signaling technology(s) with early therapeutic leads against ovarian cancer. The Company is focused on small molecule agonists and antagonists to lipid-protein signaling interactions which are new and important therapeutic targets. Echelon has assembled a unique scientific team and developed a strong intellectual property portfolio in the field of specialized cellular phospholipids which are elements in signaling pathways that govern cellular morphology, motility, proliferation and death. Aberrations in lipid-protein signaling interactions are involved in many diseases, including cancer, diabetes, cardiovascular disorders, and a variety of inflammatory and autoimmune conditions. | |
|
|
|
|
|
|
|
